News > Research Highlights

Page 8 of 38

The Institute of Molecular Biology and Biotechnology of FORTH joins EU-LIFE as a new Associate Member
The Institute of Molecular Biology and Biotechnology of FORTH joins  EU-LIFE as a new Associate Member
Jul 16, 2020
In July 1st 2020, the Institute of Molecular Biology and Biotechnology (IMBB) of the Foundation for Research and Technology-Hellas (FORTH) was officially accepted as an Associate Member of EU-LIFE. EU-LIFE is an alliance of leading European research institutes in the life sciences with a mission to promote excellence in research, by implementing and disseminating best practices in the organization and operation of scientific establishments. Its members operate with similar principles of excellence, external reviews, independence, competitiveness and internationality.
Professor Nektarios Tavernarakis elected Member of the European Institute of Innovation and Technology Governing Board
Professor Nektarios Tavernarakis elected Member of the European Institute of Innovation and Technology Governing Board
Jul 06, 2020
Nektarios Tavernarakis, Chairman of the Board of Directors at the Foundation for Research and Technology-Hellas (FORTH), and Professor at the Medical School of the University of Crete, was elected Member of the European Institute of Innovation and Technology (EIT) Governing Board.
Neuroimplants to treat spinal cord injuries
Neuroimplants to treat spinal cord injuries
Jun 16, 2020
A pioneering research study by researchers at the Institute of Molecular Biology & Biotechnology of FORTH and the University of Crete suggests the development of neuroimplants for the regeneration of nerve tissue in cases of spinal cord injury. The materials and cells used are non-toxic for humans, and approved from FDA for their immediate translation in humans.
FORTH coordinates the National Precision Medicine Network for Neurodegenerative Diseases
FORTH coordinates the National Precision Medicine Network for Neurodegenerative Diseases
Jun 03, 2020
A new emblematic initiative, the National Network for Neurodegenerative Disease Research towards Precision Medicine, commences its operation in Greece. This flagship initiative positions Greece at the forefront of neurodegeneration and ageing research, with initial funding of € 2.2 million, over a two-year implementation period, provided by the Ministry of Development and Investments, through the General Secretariat for Research and Technology. The pioneering Network comprises leading National Research Centers and Universities, and is coordinated by the Foundation for Research and Technology - Hellas (FORTH), with the National and Kapodistrian University of Athens (NKUA) as co-coordinator.